In addition to preventive measures, the Medical Oncology department provides diagnosis and treatment for most types of cancer. Treatment and follow-up plans for cancer patients are drawn up using a multidisciplinary approach, in collaboration with the departments of surgery, radiology, pathology, nuclear medicine, internal medicine and radiation oncology. During and after treatment, patients are looked after by a medical care team as well as a palliative care team that includes specialists in algology (pain management), nutrition and psychology.
The treatments provided by our oncologists include:
- Chemotherapy
- Immunotherapy
- Targeted molecular therapies
- Hormone therapy
- Other systemic treatments
Immunotherapy (also called biological treatment or biotherapy) is a type of treatment that stimulates the body's immune system to fight cancer. Immunotherapy covers a range of treatments that act in different ways: some aim to strengthen the immune system's general defences; others help the immune system recognise cancer cells specifically and attack them.
We offer every cancer patient personalised treatments. Next-generation sequencing is generally used to detect the specific mutations present in the tumour tissue. These treatments are delivered by expert doctors and oncology nurses with daily experience of caring for cancer patients.
Medicines can be given in different ways. Some are chemotherapy (cytotoxic) agents intended to destroy tumour cells, while others prevent tumours from growing and spreading (targeted agents, cytostatics). Other groups of medicines include hormones and supportive treatments.
Some types of tumour are sensitive only to chemotherapy. Some tumours require chemotherapy and radiotherapy to be given in succession or at the same time, while others may require chemotherapy before or after surgery. The duration and frequency of administration depend entirely on the chemotherapy protocol chosen according to the patient's condition.
Bülent Karagöz
MD, Prof. Dr., Professor of Medical Oncology
Oncological Sciences – Medical Oncology
Bülent Karagöz
MD, Prof. Dr., Professor of Medical Oncology
Oncological Sciences – Medical Oncology
Education and career
• Faculty of Military Medicine, Gülhane Military Medical Academy, 1986-1992.
• GATA Haydarpaşa University Hospital, specialisation in internal medicine, 1995-1999
• GATA Haydarpaşa University Hospital, specialisation in medical oncology, 2003-2006.
Activities and medical areas of interest
• Tumour biology
• Tumour immunology
• Cancer immunotherapy
• Targeted therapies
Memberships:
• Turkish Society of Medical Oncology
Research and publications
• 50 international publications
Training attended
• Tumour biology training, Medical Oncology Association, 2003.
• Applied flow cytometry training, Istanbul University (DETAE), 2004.
• Basic epidemiology (research methods and analysis techniques in the field of health)
• Training, GATA Command, 2005.
• Training in the ethical approach to clinical research, Ministry of Health, General
Directorate of Medicines and Pharmacy, 2009 and 2017 (twice).
Şeref Kömürcü
Şeref Kömürcü
MD, Professor of Medical Oncology
Oncology – Medical Oncology
Education and career
• Hacettepe University, Faculty of Medicine, Ankara 1983
• Gülhane Military Medical Academy, Ankara 1986
• Gülhane Military Medical Academy, Department of Internal Medicine, Ankara 1993
• Gülhane Military Medical Academy, Department of Medical Oncology, Ankara 1996
• Gülhane Military Medical Academy, Department of Medical Oncology, Ankara 1996-1999
• Gülhane Military Medical Academy, Department of Medical Oncology, Ankara 1999-2008
• Gülhane Military Medical Academy, Department of Medical Oncology, Ankara 2008-2011
Activities and medical areas of interest
• Solid tumours
• Breast cancer
• Colorectal cancer and skin cancer
• Palliative medicine
• Supportive care in oncology
Research and publications
• More than 110 articles published in national and international journals
• More than 100 papers presented at scientific conferences and congresses
Memberships
• American Society of Clinical Oncology (ASCO)
• European Society for Medical Oncology (ESMO)
• Multinational Association of Supportive Care in Cancer (MASCC)
• Cleveland Clinic Alumni Association (1998-2006)
• Turkish Oncology Group
• Turkish Society of Medical Oncology
• Lung Cancer Organisation
• Medical Communication Organisation
• Breast Diseases Association
